Literature DB >> 18401577

Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals.

Francesco Lapi1, Enrica Cecchi, Claudio Pedone, Francesco Attanasio, Grazia Banchelli, Alfredo Vannacci, Marina Di Pirro, Martina Moschini, Valentina Berni, Rosanna Matucci, Elisabetta Cini, Antonino Scalia, Enrico Tendi, Alessandro Mugelli.   

Abstract

BACKGROUND: More than 380,000 angiographic procedures are performed every year in Italian hospitals, with an increase rate of 8% per year. Although contrast media (CM) are considered relatively safe, adverse drug reactions (ADRs) remain an important issue.
OBJECTIVES: The objective of this study was to quantify the incidence of immediate and delayed nonrenal ADRs to iodinated CM in an Italian cohort and to evaluate whether their different physicochemical properties are able to affect the incidence of immediate or delayed ADRs.
METHODS: A prospective intensive monitoring study was conducted on a cohort of patients undergoing radiodiagnostic procedures with iodinated CM enrolled in two hospitals in Tuscany, Italy. To evaluate both immediate (within 1 h after CM administration) and delayed (>1 h to 1 week after CM administration) ADRs to CM, two questionnaires were administered. Adverse events (AEs) were analyzed to check the causality assessment between CM and ADR. If more than one symptom occurred in the same patient, they were treated as a single event.
RESULTS: One thousand five hundred and fourteen subjects who were exposed to iodinated CM completed the questionnaires. Mean age [standard deviation (SD)] was 65.4 (13.3) years, and 57.9% were male patients. A total of 178 [11.8%; 95% confidence interval (CI) 10.1-13.4] ADRs were reported. Thirty-four (2.2%; 1.5-3.1) and 144 (9.5%; 8.0-11.1) developed immediate and delayed ADRs, respectively. Both types of ADRs were experienced by six subjects (0.4%; 0.1-0.8). One hundred and seventy-six cases (98.8%; 96.0-99.8) were classified as possible and two (1.1%; 0.1-3.9) as probable ADRs. Monomeric low-osmolal (iopromide, iomeprol, iobitridol) and dimeric iso-osmolal (iodixanol) groups mainly reported delayed allergy-like ADRs of mild severity. Only one immediate reaction was severe. Multivariate analysis confirmed a higher risk of immediate reactions occurring for monomeric CM (OR 4.3; 95% CI 1.2-15.7), whereas the risk of delayed ADRs was significantly higher for the dimeric group (OR 1.8; 1.1-2.5).
CONCLUSIONS: Monomeric CM were more frequently involved in immediate ADRs, whereas dimeric CM were involved in delayed reactions. Although severe life-threatening ADRs to CM were confirmed to be rare, due to the large use of these drugs, they still retain clinical and epidemiological significance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18401577     DOI: 10.1007/s00228-008-0477-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  35 in total

1.  Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.

Authors:  A G Sutton; P Finn; E D Grech; J A Hall; M J Stewart; A Davies; M A de Belder
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

2.  The radiocontrast molecule in anaphylaxis: a surprising antigen.

Authors:  Elliott C Lasser
Journal:  Novartis Found Symp       Date:  2004

3.  Editorial: contrast medium-induced nephropathy.

Authors:  Pontus B Persson
Journal:  Nephrol Dial Transplant       Date:  2005-02       Impact factor: 5.992

4.  Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Authors:  Roberto Leone; Anita Conforti; Mauro Venegoni; Domenico Motola; Ugo Moretti; Ilaria Meneghelli; Alfredo Cocci; Giulia Sangiorgi Cellini; Stefania Scotto; Nicola Montanaro; Giampaolo Velo
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Management of hypersensitivity reactions to iodinated contrast media.

Authors:  K Brockow; C Christiansen; G Kanny; O Clément; A Barbaud; A Bircher; P Dewachter; J-L Guéant; R-M Rodriguez Guéant; C Mouton-Faivre; J Ring; A Romano; J Sainte-Laudy; P Demoly; W J Pichler
Journal:  Allergy       Date:  2005-02       Impact factor: 13.146

6.  Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial.

Authors:  Hans H Schild; Christiane K Kuhl; Ute Hübner-Steiner; Ingrid Böhm; Ulrich Speck
Journal:  Radiology       Date:  2006-05-23       Impact factor: 11.105

Review 7.  The etiology of contrast medium reactions.

Authors:  T Almén
Journal:  Invest Radiol       Date:  1994-05       Impact factor: 6.016

8.  The current status of reactions to intravenous contrast media.

Authors:  G Ansell; M C Tweedie; C R West; P Evans; L Couch
Journal:  Invest Radiol       Date:  1980 Nov-Dec       Impact factor: 6.016

Review 9.  Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.

Authors:  M D Drici; N Clément
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 10.  Prevention of generalized reactions to contrast media: a consensus report and guidelines.

Authors:  S K Morcos; H S Thomsen; J A Webb
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

View more
  7 in total

1.  Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department.

Authors:  M García; U Aguirre; A Martinez; B Ruiz; U Lertxundi; C Aguirre
Journal:  Br J Radiol       Date:  2013-11-04       Impact factor: 3.039

2.  Late adverse reactions to intravascular iodine based contrast media: an update.

Authors:  Marie-France Bellin; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Olivier Clement; Gertraud Heinz-Peer; Peter Reimer; Aart van der Molen
Journal:  Eur Radiol       Date:  2011-07-16       Impact factor: 5.315

3.  Potential drug-drug interactions and radiodiagnostic procedures: an in-hospital survey.

Authors:  F Lapi; M Vietri; M Moschini; E Cecchi; A Pugi; E Lucenteforte; G Banchelli; M Di Pirro; E Gallo; A Mugelli; A Vannacci
Journal:  Pharm World Sci       Date:  2010-02-05

4.  Swallowing study using water-soluble contrast agents may increase aspiration sensitivity and antedate oral feeding without respiratory and drug complications: A STROBE-compliant prospective, observational, case-control trial.

Authors:  Chang Ho Hwang
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

5.  Contrast-media-induced hypersensitivity or allergic/allergic-like reactions? Suggestion for a more appropriate use of the nomenclature.

Authors:  Ingrid Böhm; Hans Schild
Journal:  Eur J Clin Pharmacol       Date:  2008-08-06       Impact factor: 2.953

6.  PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial.

Authors:  M Picardi; C Cavaliere; R Della Pepa; E Nicolai; A Soricelli; C Giordano; N Pugliese; M G Rascato; I Cappuccio; G Campagna; C Cerchione; E Vigliar; G Troncone; M Mascolo; M Franzese; R Castaldo; M Salvatore; F Pane
Journal:  Ann Hematol       Date:  2021-04-28       Impact factor: 3.673

7.  Induction of upregulation and downregulation of the T-cell activation marker CD98 in patients undergoing contrast-enhanced CT with iodinated non-ionic dimeric contrast medium.

Authors:  Ingrid Böhm; Hans H Schild
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.